Paper Review Records
全部论文审稿周期
25 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
78
天
From molecular pathogenesis to novel Therapeutic approaches - a review of recent advances in the treatment of peripheral T cell Lymphomas
作者
Wee Lee Chan; Wee Joo Chng; Qi-Jing Li展开收起
作者单位
1. Department of Haematology-Oncology, National University Cancer Institute Singapore, National University Hospital, National University Health System, Singapore, Singapore; 2. Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research, Singapore (A*STAR), Singapore, Singapore; 3. NUS Centre for Cancer Research (N2CR), 14 Medical Drive, Centre for Translational Medicine, Singapore, Singapore; 4. Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore展开收起
58
天
HIRA loss is frequent but not universal in human fumarate hydratase-deficient renal cell carcinoma and defines divergent oncogenic programs
作者
Xu Shi; Zehua Tan; Guangxi Sun; Hao Zeng; Xingming Zhang展开收起
作者单位
1. Department of Urology, Institute of Urology, Sichuan Clinical Research Center for Kidney and Urologic Diseases, West China Hospital, Sichuan University, Chengdu, China展开收起
119
天
Multidimensional 5-hydroxymethylcytosine features in cell-free DNA enable the detection, staging and subtyping of pancreatic ductal adenocarcinoma
作者
Haoyu Shi; Cheng Qin; Yutong Zhao; Lirui Huang; Zeru Li; Tianyu Li; Bangbo Zhao; Weibin Wang展开收起
作者单位
1. Department of General Surgery, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 2. Key Laboratory of Research in Pancreatic Tumor, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China; 3. National Science and Technology Key Infrastructure on Translational Medicine, Peking Union Medical College Hospital, Beijing, People’s Republic of China展开收起
97
天
Clinical implications of serum GDF15 propeptide as a biomarker for bone metastasis across common solid tumors: a real-world multi-institutional study
作者
Gaku Yamamichi; Taigo Kato; Atsuki Matsukawa; Nanae Masunaga; Haruhiko Hirata; Jun Okuno; Norihiko Kawamura; Kei Kunimasa; Ikumi Seto; Takanori Kin; Kentaro Masuhiro; Shinya Sato; Shohei Myoba; Shinobu Ikeda; Takeshi Ujike; Yu Ishizuya; Takuji Hayashi; Yoshiyuki Yamamoto; Koji Hatano; Atsunari Kawashima; Yohei Miyagi; Motohide Uemura; Kazumi Nishino; Takahiro Nakayama; Masashi Nakayama; Yoshito Takeda; Kenzo Shimazu; Norio Nonomura展开收起
作者单位
1. Department of Urology, The University of Osaka Graduate School of Medicine, Suita, Japan; 2. Department of Breast and Endocrine Surgery, The University of Osaka Graduate School of Medicine, Suita, Japan; 3. Department of Respiratory Medicine and Clinical Immunology, The University of Osaka Graduate School of Medicine, Suita, Japan; 4. Department of Breast and Endocrine Surgery, Osaka International Cancer Institute, Osaka, Japan; 5. Department of Urology, Osaka International Cancer Institute, Osaka, Japan; 6. Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan; 7. Molecular Pathology and Genetics Division, Kanagawa Cancer Center Research Institute, Yokohama, Japan; 8. Bioscience Division, Research and Development Department, Tosoh Corporation, Ayase, Japan; 9. Medical Center for Translational Research, Department of Medical Innovation, The University of Osaka Hospital, Suita, Japan; 10. Department of Urology, Osaka Rosai Hospital, Sakai, Japan; 11. Department of Urology, Iwase General Hospital, Sukagawa, Fukushima, Japan; 12. Department of Urology, Fukushima Medical University School of Medicine, Fukushima, Japan展开收起
164
天
FECH, a novel metabolic target influencing CAR T-cell phenotype and function
作者
Marsha Pellegrino; Simone Vespa; Illari Salvatori; Giang Dang Mac; Cristiana Valle; Valerio Secli; Sara Cairoli; Bianca Maria Goffredo; Matteo Caforio; Valentina Folgiero; Lokossou William Sanvi; Elisabetta Vulpis; Elena Ciampini; Marco Scarsella; Ezio Giorda; Ferdinando Chiaradonna; Manuela Giansanti; Francesca Nazio; Alberto Ferri; Francesco Cecconi; Silvia Campello; Enrico Velardi; Ignazio Caruana; Emmanuel de Billy展开收起
作者单位
1. Department of Onco-Hematology, Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; 2. Laboratory for Cell and Gene Therapy, Department of Paediatrics, Stem Cell Transplantation and Cell Therapy, University Hospital Würzburg, Würzburg, Germany; 3. Santa Lucia Foundation, IRCCS, Rome, Italy; 4. National Research Council (CNR), Institute of Translational Pharmacology (IFT), Rome, Italy; 5. Bambino Gesù Children’s Hospital, Division of Metabolic Diseases and Drug Biology, IRCCS, Rome, Italy; 6. Department of Experimental Medicine (DIMES), University of Genova, Genova, Italy; 7. Department of Biology, University of Rome Tor Vergata, Rome, Italy; 8. Department of Basic Biotechnological Sciences, Intensive Care and Perioperative Clinics Research, Catholic University of the Sacred Heart, Rome, Italy; 9. Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy; 10. Department of Biotechnology and Biosciences, University of Milano-Bicocca, Milan, Italy; 11. Innate Lymphoid Cells Unit, Immunology Research Area, Bambino Gesù Children’s Hospital IRCCS, Rome, Italy; 12. Catholic University of the Sacred Heart, Rome, Italy; 13. Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; 14. Department of Pediatrics - Hematology, Oncology, Stem Cell Transplantation and Cell Therapy, University Hospital Würzburg, Würzburg, Germany展开收起
160
天
Biomarker implications of gene editing in hematologic diseases: latest updates from ASH 2025
作者
Zezhou Zang; Wei Zheng; Ruirong Xu; Siyuan Cui展开收起
作者单位
1. Shandong University of Traditional Chinese Medicine, Jinan, China; 2. Department of Hematology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China; 3. Institute of Hematology, Shandong University of Traditional Chinese Medicine, Jinan, China展开收起
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿62 天
中位数65 天